First human tests for hepatitis b drug halted
NCT ID NCT05763576
Summary
This early study tested a new drug called RO7565020 to see if it's safe for people with chronic hepatitis B. Researchers gave the drug to 60 healthy volunteers and hepatitis B patients to check for side effects and how the body processes it. The study was terminated after this initial safety phase.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chang Gung Medical Foundation Linkou Branch
Taoyuan, 333, Taiwan
-
Faculty of Medicine Siriraj Hospital
Bangkok, 10700, Thailand
-
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, 24253, South Korea
-
Hospital Alvaro Cunqueiro
Vigo, Pontevedra, 36312, Spain
-
Maharaj Nakorn Chiang Mai Hospital
Chiang Mai, 50200, Thailand
-
New Zealand Clinical Research - Auckland
Auckland, 1010, New Zealand
-
Prince of Wales Hospital
Shatin, New Territories, Hong Kong
-
Queen Mary Hospital
Hong Kong, Hong Kong
-
Quest Clinical Research
San Francisco, California, 94115, United States
Conditions
Explore the condition pages connected to this study.